Capital Research Global Investors Edwards Lifesciences Corp Transaction History

Capital Research Global Investors

$466 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $20,180 - $26,286	245 Added 0.04%	670,407 $55.4 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $83.5 Million - $105 Million	-818,854 Reduced 54.99%	670,162 $78.9 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $522 Million - $642 Million	-4,909,845 Reduced 76.73%	1,489,016 $193 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $47.9 Million - $57.2 Million	465,759 Added 7.85%	6,398,861 $724 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $213 Million - $266 Million	-2,539,275 Reduced 29.97%	5,933,102 $614 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $141 Million - $162 Million	-1,786,094 Reduced 17.41%	8,472,377 $709 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $18.5 Million - $23.6 Million	-258,468 Reduced 2.46%	10,258,471 $936 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $33 Million - $43 Million	-491,885 Reduced 4.47%	10,516,939 $839 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $400 Million - $535 Million	6,957,002 Added 171.7%	11,008,824 $761 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $32.5 Million - $50.3 Million	-620,927 Reduced 13.29%	4,051,822 $764 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $10.9 Million - $12.5 Million	152,377 Added 3.37%	4,672,749 $1.09 Billion
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $36.6 Million - $44.9 Million	-595,229 Reduced 11.64%	4,520,372 $994 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $84.9 Million - $98.1 Million	1,522,944 Added 42.39%	5,115,601 $945 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $10.3 Million - $13.7 Million	-214,649 Reduced 5.64%	3,592,657 $687 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $12.2 Million - $14.9 Million	262,040 Added 7.39%	3,807,306 $583 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $101 Million - $128 Million	2,206,539 Added 164.82%	3,545,266 $617 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $56.8 Million - $68.7 Million	1,338,727 New	1,338,727 $195 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $13.5 Million - $15.8 Million	-400,386 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $14.5 Million - $15.5 Million	400,386	400,386 $43.8 Million

Others Institutions Holding EW

# of Institutions

1,370

Shares Held

482M

Call Options Held

9.66M

Put Options Held

3.83M

Vanguard Group Inc Valley Forge, PA

69.1M
Shares

$5.24 Billion
0.09% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.86 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

33.2M
Shares

$2.52 Billion
0.46% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.99 Billion
0.07% of portfolio
Jpmorgan Chase & CO New York, NY

14.9M
Shares

$1.13 Billion
0.09% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account